Merck and Ridgeback Biotherapeutics’ antiviral of the moment, molnupiravir, appears likely to become the first oral treatment approved for Covid-19, after interim analysis showed the pill lowered the ...
Dublin, March 08, 2023 (GLOBE NEWSWIRE) -- The "Molnupiravir Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Application (Influenza, Ebola, COVID-19, ...
SHANGHAI (Reuters) - Pfizer and Merck have slightly lowered the prices of their respective Paxlovid and molnupiravir COVID-19 treatments in China, local media reported on Tuesday citing pricing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback